Prescribing overview
Comfortis provides flea treatment and prevention for dogs and cats. Dog and cat weight schedules differ; the product does not replace broader parasite prevention when that is needed.
Comfortis provides flea treatment and prevention for dogs and cats. Dog and cat weight schedules differ; the product does not replace broader parasite prevention when that is needed.
Key prescribing checks
- Confirm the indication, route, current weight, disease status and concurrent treatments before prescribing.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Dogs and Cats
FDA-approved canine/feline productPrevention and treatment of flea infestations
US dogs and cats at least fourteen weeks old; minimum weights are 5 lb for dogs and 4.1 lb for cats.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Activates insect nicotinic acetylcholine receptors, producing flea paralysis and death.
Absorption, distribution, metabolism and elimination
Food improves effectiveness; quantitative species kinetics were not established in this review.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Comfortis
US dogs and cats at least fourteen weeks old; minimum weights are 5 lb for dogs and 4.1 lb for cats.
Contraindications · when not to use
- The label reports no known contraindications; age, weight and precaution restrictions still apply.
Precautions & monitoring
- Use caution with canine epilepsy and breeding females. Male-dog and feline reproductive safety has not been established.
Selected product information; this is not a complete interaction or patient-specific prescribing assessment.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Vomiting is prominent; appetite loss, lethargy, diarrhea and neurologic events have also been reported.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
No numeric regimen is supplied in this entry. The veterinarian must consult the exact current product label; this entry does not enable a dosing calculator.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Comfortis
US dogs and cats at least fourteen weeks old; minimum weights are 5 lb for dogs and 4.1 lb for cats.
- Extra-label ivermectin with Comfortis has caused serious reactions in dogs; feline labeling also advises caution. This differs from labeled heartworm-preventive use.
Monitoring
Confirm species-specific presentation and monitor gastrointestinal or neurologic signs.
Client counseling
Give with food. Review the full parasite-prevention plan and any vomiting after treatment before repeating a dose. Persistent emerging fleas may reflect environmental stages.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow the original package storage directions and prevent accidental consumption.
Brands, formulations & ingredient identity
Active ingredients
Spinosad
Other searchable names: Comfortis
This reference is limited to the named product and presentation; matching ingredients do not establish interchangeability.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Comfortis
- Formulation
- Species-specific oral chewable tablets
- Label / product scope
- Dogs · Cats
US dogs and cats at least fourteen weeks old; minimum weights are 5 lb for dogs and 4.1 lb for cats.
Product label / source ↗References & review status
Clinical reference updated October 27, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
